Maintenance. We are currently updating the site. Please check back shortly

Thomson Reuters Foundation

Inform - Connect - Empower

U.S. FDA cracks down on thousands of websites for selling bad drugs

Source: Thomson Reuters Foundation - Thu, 4 Oct 2012 13:30 GMT
Author: Reuters
Tweet Recommend Google + LinkedIn Email Print
Leave us a comment

Oct 4 (Reuters) - The U.S. Food and Drug Administration on Thursday said it has cracked down on thousands of online pharmacies for selling potentially unsafe, unapproved or fake pharmaceuticals, including the erectile dysfunction drug Viagra and antiviral Tamiflu.

The FDA, working with international regulatory and law enforcement agencies from about 100 countries, said it took action against more than 4,100 Internet pharmacies, bring civil and criminal charges, removing offending websites and seizing drugs worldwide.

The move was part of the fifth annual International Internet Week of Action, a global effort to fight the online sale and distribution of potentially counterfeit and illegal medicine.

Action taken between Sept. 25 and Oct. 2 resulted in the shutdown of more than 18,000 illegal pharmacy websites and the seizure of ${esc.dollar}10.5 million worth of drugs.

The goal of this annual effort, which involved law enforcement, customs and regulatory authorities from 100 countries, was to identify producers and distributors of illegal pharmaceutical products and medical devices and remove these products from the supply chain.

The FDA targeted websites selling unapproved and potentially dangerous medicines. In addition to Tamiflu and Viagra, the agency targeted Domperidone, which was removed from the U.S. market in 1998 because it may cause serious adverse side effects, and Isotretinoin, previously marketed as Accutane in the United States, used to treat severe acne and carries risks, such as birth defects.

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of the Thomson Reuters Foundation. For more information see our Acceptable Use Policy.

comments powered by Disqus
Most Popular
LATEST SLIDESHOW

Latest slideshow

See allSee all
FEATURED JOBS
Featured jobs